Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study
MR Loutfy, LM Blatt, KA Siminovitch, S Ward, B Wolff… - Jama, 2003 - jamanetwork.com
ContextSevere acute respiratory syndrome (SARS) is a new clinical entity for which no
effective therapeutic strategy has been developed. ObjectiveTo provide preliminary results
on the potential therapeutic benefit and tolerability of interferon alfacon-1 plus
corticosteroids for SARS. Design, Setting, and PatientsOpen-label study of 22 patients
diagnosed as having probable SARS at North York General Hospital, Toronto, Ontario,
between April 11 and May 30, 2003. InterventionsThirteen patients were treated with …
effective therapeutic strategy has been developed. ObjectiveTo provide preliminary results
on the potential therapeutic benefit and tolerability of interferon alfacon-1 plus
corticosteroids for SARS. Design, Setting, and PatientsOpen-label study of 22 patients
diagnosed as having probable SARS at North York General Hospital, Toronto, Ontario,
between April 11 and May 30, 2003. InterventionsThirteen patients were treated with …
